DEEPAK SHARMA: Open Payments
NPI 1053956292 · SYCAMORE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 32 payments from 11 companies in 2025. Trend: 2023 $522 · 2024 $998 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $178 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $141 |
| Novo Nordisk Inc | 3 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| ABBVIE INC. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $24 |
| PFIZER INC. | 1 | $18 |
Products named: JARDIANCE, OTEZLA, EVENITY, Ozempic, XIFAXAN, AIRSUPRA, VRAYLAR, CAPLYTA.
Industry payments across IL — which companies pay providers there.
